Short period of exercise causes rapid increase of serum interleukin 6 with no effect on its soluble receptor

Archives of Medical Science

Volumn 5, Issue 3, 2009, Pages 364-370

  Kamiński, Karol A ^a   Jasiewicz, Małgorzata ^a   Knapp, Małgorzata ^a   Jackowska, Anna ^a   Latocha Korecka, Grazyna ^a   Waszkiewicz, Ewa ^a   Musiał, Włodzimierz J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Exercise; Exercise test; Il 6 receptor; Interleukin 6

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; EXERCISE TEST; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

EID: 73449114960     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Walther C, Mobius-Winkler S, Linke A, et al. Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2008; 15: 107-12.
2. Pedersen BK, Febbraio M. Muscle-derived interleukin-6 - a possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav Immun 2005; 19: 371-6.
3. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-72.
4. Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-6.
5. Dawn B, Xuan YT, Guo Y, et al. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 2004; 64: 61-71.
6. Schieffer B, Selle T, Hilfiker A, et al. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004; 110: 3493-500.
7. Pedersen BK, Fischer CP. Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care 2007; 10: 265-71.
8. Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 2007; 11: 613-24.
9. Keller P, Penkowa M, Keller C, et al. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 2005; 19: 1181-3.
10. Nielsen S, Pedersen BK. Skeletal muscle as an immunogenic organ. Curr Opin Pharmacol 2008; 8: 346-51.
11. Hryniewicz A, Bialuk I, Kaminski KA, Winnicka MM. Impairment of recognition memory in interleukin-6 knockout mice. Eur J Pharmacol 2007; 577: 219-20.
12. Kaminski KA, Oledzka E, Bialobrzewska K, et al. The effects of moderate physical exercise on cardiac hypertrophy in interleukin 6 deficient mice. Adv Med Sci 2007; 52: 164-8.
13. Robson-Ansley P, Barwood M, Canavan J, et al. The effect of repeated endurance exercise on IL-6 and sIL-6R and their relationship with sensations of fatigue at rest. Cytokine 2009; 45: 111-6.
14. Gray SR, Robinson M, Nimmo MA. Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men. Cell Stress Chaperones 2008; 13: 247-51.
15. Balkau B, Mhamdi L, Oppert JM, et al. Physical activity and insulin sensitivity: the RISC study. Diabetes 2008; 57: 2613-8.
16. Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-740.
17. Hill J, Timmis A. Exercise tolerancetesting. BMJ 2002; 324: 1084-7.
18. Keller C, Steensberg A, Pilegaard H, et al. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 2001; 15: 2748-50.
19. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339-42.
20. Kaminski K, Kozuch M, Bonda T, et al. The effect of interleukin 6 deficiency on Bcl-2 and Bax expression in the murine heart. Pharmacological Reports 2009; 61 in press.
21. Mysliwiec J, Zbucki R, Winnicka MM, et al. A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in mice. Horm Metab Res 2007; 39: 884-8.
22. Miki T, Miura T, Tanno M, et al. Interruption of signal transduction between G protein and PKC-epsilon underlies the impaired myocardial response to ischemic preconditioning in postinfarct remodeled hearts. Mol Cell Biochem 2003; 247: 185-93.
23. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003; 107: 3109-16.
24. Mitsui T, Shimaoka K, Tsuzuku S, Kajioka T, Sakakibara H. Gentle exercise of 40 minutes with dietary counseling is effective in treating metabolic syndrome. Tohoku J Exp Med 2008; 215: 355-61.
25. Laufs U, Werner N, Link A, et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220-6.
26. Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 2004; 116: 693-706.
27. Starnes JW, Taylor RP. Exercise-induced cardioprotection: endogenous mechanisms. Med Sci Sports Exerc 2007; 39: 1537-43.
28. Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 1998; 508: 949-53.
29. Kaminski K, Kozuch M, Bonda T, et al. Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction. Atherosclerosis 2009, doi: 10.1016/j.atherosclerosis.2009.03.033.